Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
, neuroscientists, computer scientists, clinicians, and data scientists across the Singapore-ETH Centre (SEC), the National University of Singapore (NUS), and Nanyang Technological University (NTU), the PhD student
-
competitive research program in molecular immunology, with a potential for therapeutic translation. The professorship focuses on understanding how the immune system interacts with diverse tissue environments
-
100%, Zurich, fixed-term The Clinical Genomics team led by Dr. André Kahles at the Biomedical Informatics Lab (BMI Lab), headed by Prof. Gunnar Rätsch, at ETH Zurich, is seeking a highly motivated
-
operations that are yet to be fully understood. In this context, it is evident that the operation, control, and planning of power systems will soon be pushed to their limits. Therefore, new computational
-
organised individual to support multiple experimental and computational research groups. The successful candidate will contribute to both a collaborative research network and institute-wide activities
-
100%, Basel, fixed-term The Computational Biology (CoBi) group, led by Prof. Dagmar Iber, develops data-driven, mechanistic models of biological systems using advanced imaging and computational
-
-phonon coupling elements. With these, dedicated scattering rates can be computed and then used in quantum transport simulations. Down the line, we aim to pre-train a common GNN backbone model capable
-
dynamical systems, and machine learning, with applications to synthetic biology and biomolecular circuit design. Our research develops mathematical and computational frameworks for understanding and
-
work closely with Professor Platt, guide the group’s computational research, contribute to ongoing projects, and pursue independent research directions aligned with the laboratory’s goals. Project
-
100%, Basel, fixed-term The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc program, part of the Next-gen Bioengineers initiative, is run jointly by ETH Zurich and Roche